DrugPatentWatch Database Preview
Pharmalucence Company Profile
What is the competitive landscape for PHARMALUCENCE, and what generic and branded alternatives to PHARMALUCENCE drugs are available?
PHARMALUCENCE has fifteen approved drugs.
Drugs and US Patents for Pharmalucence
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pharmalucence | SELENOMETHIONINE SE 75 | selenomethionine se-75 | INJECTABLE;INJECTION | 017322-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
Pharmalucence | TECHNETIUM TC 99M SESTAMIBI | technetium tc-99m sestamibi kit | INJECTABLE;INJECTION | 079157-001 | Jul 10, 2009 | AP | RX | No | No | Start Trial | Start Trial | ||||
Pharmalucence | IODOHIPPURATE SODIUM I 131 | iodohippurate sodium i-131 | INJECTABLE;INJECTION | 017313-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
Pharmalucence | HEPATOLITE | technetium tc-99m disofenin kit | INJECTABLE;INJECTION | 018467-001 | Mar 16, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Pharmalucence
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pharmalucence | IOBENGUANE SULFATE I 131 | iobenguane sulfate i-131 | INJECTABLE;INJECTION | 020084-001 | Mar 25, 1994 | 4,584,187 | Start Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.